Skip to main content
. 2010 Aug 16;9:217. doi: 10.1186/1476-4598-9-217

Figure 5.

Figure 5

FLLL32 inhibited STAT3 DNA binding activity in (A) SW480 colorectal cancer cells, (B) U87 glioblastoma cells, and (C) U266 multiple myeloma cells (* P < 0.05).